Drug Profile
Thrombin - Ethicon/OMRIX Biopharmaceuticals
Alternative Names: Evithrom; Human plasma-derived thrombinLatest Information Update: 24 Nov 2021
Price :
$50
*
At a glance
- Originator Ethicon; OMRIX Biopharmaceuticals
- Class Antifibrinolytics; Antihaemorrhagics; Blood coagulation factors; Coagulants; Recombinant proteins; Serine endopeptidases
- Mechanism of Action Thrombin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Surgical blood loss
Most Recent Events
- 15 Oct 2007 Launched for Surgical blood loss in USA (Topical)
- 27 Aug 2007 Registered for Surgical blood loss in USA (Topical)
- 06 Nov 2006 Preregistration for Surgical blood loss in USA (Topical)